(Q44210675)

30 November 2017

0 references

Cholesterol lowering and the reduction of CHD incidence and total mortality: results from a meta-analysis of randomized trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1390319

21 September 2022

author name string

I. Holme

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1390319

21 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1390319

21 September 2022

publication date

1 April 1992

1 reference

Cardiovascular Drugs and Therapy

30 November 2017

published in

1 reference

30 November 2017

volume

6

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

101-102

1 reference

W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators

30 November 2017

cites work

1 reference

12 December 2020

An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence

1 reference

12 December 2020

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

12 December 2020

A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00054555

1 reference

30 November 2017

1 reference